A pharmaceuticals company, Bafna Pharmaceuticals (Official Site) Ltd is planning to enter the capital markets.
What is the size of Bafna Pharma IPO?
A total of 64,00,000 equity shares will be offered for sale through the Bafna Pharma IPO. The issue to the public would constitute 40.05 per cent of the post issue paid-up capital.
What is the price of each share of Bafna Pharma IPO?
The Bafna Pharma IPO share will have a face value of Rs. 10 and will be offered for cash at a premium of Rs. 30 per share.
When will the Bafna Pharma IPO open for subscription?
The Bafna Pharma IPO will accept applications between May 27 and May 30, 2008
Where will the IPO proceeds be used for Bafna Pharma IPO?
Proceeds from the IPO would be utilized towards brand building in the domestic and international markets. Bafna would also strengthen its R&D facility at Grantlayon plant, besides getting MHRA certification. It also proposes to retire high-cost debts.
What are the business valuations and financial results of Bafna Pharma?
As per ET,The Chennai-based company is engaged in the manufacturing of Betalactum and non- Betalactum pharmaceutical formulations in tablets, capsules and liquid forms. Bafna manufactures 126 formulations under various therapeutic segments such as anti-infectiv, cholesterol lowering agents, analgesic and antipyretic, antihelmintics, appetite stimulants, cough and cold preparations, anti-ulcerants and anti diabetic, vitamins.
The company has a WHO-GMP certified manufacturing facility at Madhavaram, which is a 100 per cent export oriented unit that caters to the markets of Sri Lanka, Ghana and Ukraine. Bafna has obtained 336 product licenses and has 65 products registered in various countries such as Sri Lanka, Ukraine, Ghana and Lao.
| Investors who believe in pharma stocks performance can bet their money on this Bafna Pharma IPO. Let’s see how this Bafna Pharma IPO performs in the markets! | Table of Contents |
No comments:
Post a Comment